Skip to content

Short pulses in neurostimulation for Parkinson's Disease

Short pulses in neurostimulation for Parkinson's Disease - SPIN-PD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017528
Enrollment
30
Registered
2019-11-06
Start date
2019-08-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: Deep brain stimulation with a pulse width of 30µs for 4 weeks, followed by a deep brain stimulation with 60µs for 4 weeks. Group 2: Deep brain stimulation with a pulse width of 60µs for 4 wee

Sponsors

Klinik und Poliklinik für Neurologie der Universitätskliniken zu Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Bilateral Implantation of electrodes for deep brain stimulation of the subthalamic nucleus for the treatment of idiopathic Parkinson's disease: a. at least 3 months prior to study participation b. the implanted pulse generator enables a pulse width of 30µs per clinical routine (Boston Scientific Vercise, Vercise PC and Gevia; Abbott Medical Infinity DBS System 2. The patient is not allowed to participate at another studies during which an adjustment of medication or stimulation parameters is needed at the same time 3. Patients need to agree with video and voice recordings and sign a patient consent form

Exclusion criteria

Exclusion criteria: Inclusion criteria not completed.

Design outcomes

Primary

MeasureTime frame
- Motor Diary during the last three days before the next follow-up visit after 4 weeks of deep brain stimulation with one of the two pulse widths (30µs or 60µs) - co-primary endpoint: Unified Parkinson's disease rating scale in MedOFF/StimON at follow-up visit

Secondary

MeasureTime frame
After four weeks of deep brain stimulation with one of the two pulse widths respectively (30µs or 60µs): - energy consumption - Parkinson's disease Questionnaire 39 - Non-motor symptom scale, Non-motor symptoms questionnaire - reading of a German standard text additionally: - preferred setting after finishing the study

Countries

Germany

Contacts

Public ContactJan Niklas Petry-Schmelzer

Universitätskliniken Köln Klinik und Poliklinik für Neurologie

jan.petry-schmelzer@uk-koeln.de0221-478-84791

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026